Device Orthopedic Device

Balance Knee Revision System

Payments companies reported to CMS as associated with Balance Knee Revision System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$2.7Massociated payments (2023-2025)
35clinicians with associated payments
1company reporting

By year

2023 $534K
2024 $1.1M
2025 $1.0M

Payments reported as associated with Balance Knee Revision System, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthopaedic Surgery $1.5M
Adult Reconstructive Orthopaedic Surgery $1.2M
Sports Medicine (Orthopaedic Surgery) $198

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Balance Knee Revision System

These are the largest totals companies reported as associated with Balance Knee Revision System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Nathan Momberger Murray, UT Adult Reconstructive Orthopaedic Surgery $1,149,595.89
Thomas Calton Washington Terrace, UT Orthopaedic Surgery $1,005,350.90
Joshua Hickman Bountiful, UT Orthopaedic Surgery $358,223.48
William Long New York, NY Adult Reconstructive Orthopaedic Surgery $48,001.79
Michael Hoffman Brigham City, UT Orthopaedic Surgery $47,802.81
Cass Nakasone Honolulu, HI Orthopaedic Surgery $46,621.95
Christopher Grayson Temple Terrace, FL Orthopaedic Surgery $2,414.33
Matthew Barber Mobile, AL Orthopaedic Surgery $1,625.00
Roberto Calderon Phoenix, AZ Orthopaedic Surgery $1,281.70
Brian Chalmers New York, NY Orthopaedic Surgery $1,000.00

Prescribed Balance Knee Revision System?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.